Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Journal of Gastrointestinal Surgery
Erschienen in: Journal of Gastrointestinal Surgery 3/2009

01.03.2009 | original article

Bariatric Surgery: A History of Empiricism, a Future in Science

verfasst von: John C. Alverdy, Vivek Prachand, Brody Flanagan, William A. Thistlethwaite, Mark Siegler, Marc Garfinkel, Peter Angelos, Shailesh Agarwal, Heena Santry

Erschienen in: Journal of Gastrointestinal Surgery | Ausgabe 3/2009

Einloggen, um Zugang zu erhalten

Abstract

Background

The observation that obesity can be successfully treated by gastrointestinal surgery is a tribute to the innovative efforts by determined surgeons and the ever improving safety of general anesthesia. Yet as the body of knowledge and discovery on the root causes of human obesity accumulate, surgical approaches to treat morbid obesity are likely to change dramatically. While there is little doubt that dramatic weight loss can be achieved by surgically creating volume and absorption limitation to the reservoir and digestive functions of the gastrointestinal tract, human progress to more processed foods, less physical activity, and the pervasive public opinion that obesity is self-imposed are major obstacles to more widespread application of this approach.

Discussion

Here we provide a mechanico-physiologic analysis of current operations, their rationale and limitations, as well as a glimpse of how future interventions might develop as a result of current knowledge in the field. The future of bariatric surgery is discussed in the context of these emerging technologies and in the context of the politics of obesity.
Literatur
1.
2.
3.
4.
Anonymous. Gastrointestinal surgery for severe obesity: National Institutes of Health Consensus Development Conference Statement. Am J Clin Nutr 1992;55(suppl):615–619.
5.
Chinai R, Goswami R. Medical visas mark growth of Indian medical tourism. Bull World Health Organ 2007;85(3):164–165. Mar.PubMed
6.
Vanek VW. State laws on insurance coverage for bariatric surgery: help or a hindrance. Surg Obes Relat Dis 2005;1(4):424–429.PubMedCrossRef
7.
Jamal MK, DeMaria EJ, Johnson JM, Carmody BJ, Wolfe LG, Kellum JM, Meador JG. Insurance-mandated preoperative dietary counseling does not improve outcome and increases dropout rates in patients considering gastric bypass surgery for morbid obesity. Surg Obes Relat Dis 2006;2(2):122–127. Mar–Apr.PubMedCrossRef
8.
Shinogle JA, Owings MF, Kozak LJ. Gastric bypass as treatment for obesity: trends, characteristics, and complications. Obes Res 2005;13:2202–2209.PubMedCrossRef
9.
le Roux CW, Aylwin SJ, Batterham RL, Borg CM, Coyle F, Prasad V, Shurey S, Ghatei MA, Patel AG, Bloom SR. Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters. Ann Surg 2006;243:108–114.PubMedCrossRef
10.
Lanagan L. Measurement of functional pouch volume following the gastric bypass procedure. Obes Surg 1996;6:38–43.CrossRef
11.
Nelson WK, Fatima J, Houghton SG, Thompson GB, Kendrick ML, Mai JL, Kennel KA, Sarr MG. The malabsorptive very, very long limb Roux-en-Y gastric bypass for super obesity: results in 257 patients. Surgery 2006;140(4):517–522. discussion 522–3. Epub 2006 Sep 1, Oct.PubMedCrossRef
12.
Bessler M, Daud A, Kim T, DiGiorgi M. Prospective randomized trial of banded versus nonbanded gastric bypass for the super obese: early results. Surg Obes Relat Dis 2007;3(4):480–484. discussion 484–5. Epub 2007 Jun 4, Jul–Aug.PubMedCrossRef
13.
Christou NV, Look D, Maclean LD. Weight gain after short- and long-limb gastric bypass in patients followed for longer than 10 years. Ann Surg 2006;244:734–740.PubMedCrossRef
14.
Kellum JM, Kuemmerle JF, O’Dorisio TM, et al. Gastrointestinal hormone responses to meals before and after gastric bypass and vertical banded gastroplasty. Ann Surg 1990;211:763–771.PubMedCrossRef
15.
Cummings DE, Overduin J, Foster-Schubert KE. Gastric bypass for obesity: mechanisms of weight loss and diabetes resolution. J Clin Endocrinol Metab 2004;89:2608–2615.PubMedCrossRef
16.
Potoczna N, Branson R, Kral JG, Piec G, Steffen R, Ricklin T, Hoehe MR, Lentes KU, Horber FF. Gene variants and binge eating as predictors of comorbidity and outcome of treatment in severe obesity. J Gastrointest Surg 2004;8(8):971–981. discussion 981–2. Dec.PubMedCrossRef
17.
Prachand VN, Davee RT, Alverdy JC. Duodenal switch provides superior weight loss in the super-obese (BMI > or =50 kg/m2) compared with gastric bypass. Ann Surg 2006;244:611–619.PubMed
18.
Batterham RL, Cowley MA, Small CJ, Herzog H, Cohen MA, Dakin CL, Wren AM, Brynes AE, Low MJ, Ghatei MA, Cone RD, Bloom SR. Gut hormone PYY(3–36) physiologically inhibits food intake. Nature 2002;418:650–654.PubMedCrossRef
19.
Ley RE, Turnbaugh PJ, Klein S, Gordon JI. Microbial ecology: human gut microbes associated with obesity. Nature 2006;444(7122):1022–1023. Dec 21.PubMedCrossRef
20.
Picard M, Frédéric Simon H, Stéfane L, Simon M, Simon B. Complications of combined gastric restrictive and malabsorptive procedures: part 2. Curr Surg 2003;60(3):275–279. discussion 279–81, May–Jun.CrossRef
21.
Prakash G, Drenick EJ, Wexler H, DeLucia L, Finegold SM. Microbial flora in the bypassed jejunum of patients with biliopancreatic bypass for obesity. Am J Clin Nutr 1987;46:273–276.PubMed
22.
Zoetendal EG, Collier CT, Koike S, Mackie RI, Gaskins HR. Molecular ecological analysis of the gastrointestinal microbiota: a review. J Nutr 2004;134:465–472.PubMed
23.
Chapman AE, Kiroff G, Game P, et al. Laparoscopic adjustable gastric banding in the treatment of obesity: a systematic literature review. Surgery 2004;135:326–351.PubMedCrossRef
24.
Chapman AE, et al. Systematic review of laparoscopic adjustable gastric banding in the treatment of obesity. Surgery 2004;135:326–351.PubMedCrossRef
25.
Couzin J. MEDICINE: bypassing medicine to treat diabetes. Science 2008;320(5875):438–440. Apr 25.PubMedCrossRef
26.
Hoekstra SM, Lucas CE, Ledgerwood AM, Lucas WF. A comparison of the gastric bypass and the gastric wrap for morbid obesity. Surg Gynecol Obstet 1993;176:262–266.PubMed
27.
Curley SA, Weaver W, Wilkinson LH, Demarest GB. Late complications after gastric reservoir reduction with external wrap. Arch Surg 1987;122:781–783.PubMed
28.
Baicy K, London ED, Monterosso J, Wong ML, Delibasi T, Sharma A, Licinio J. Leptin replacement alters brain response to food cues in genetically leptin-deficient adults. Proc Natl Acad Sci U S A 2007;104(46):18276–18279. Nov 13. Epub 2007 Nov 6.PubMedCrossRef
29.
Karamanakos SN, Vagenas K, Kalfarentzos F, Alexandrides TK. Weight loss, appetite suppression, and changes in fasting and postprandial ghrelin and peptide-YY levels after Roux-en-Y gastric bypass and sleeve gastrectomy: a prospective, double blind study. Ann Surg 2008;247(3):401–407. Mar.PubMedCrossRef
30.
Baltasar A, Serra C, Perez N, Bou R, Bengochea M. Re-sleeve gastrectomy. Obes Surg 2006;16(11):1535–1538. Nov.PubMedCrossRef
31.
Mathus-Vliegen EM. Intragastric balloon treatment for obesity: what does it really offer. Dig Dis 2008;26(1):40–44. Epub 2008, Feb 15.PubMedCrossRef
32.
Pelkman CL, Navia JL, Miller AE, Pohle RJ. Novel calcium-gelled, alginate-pectin beverage reduced energy intake in nondieting overweight and obese women: interactions with dietary restraint status. Am J Clin Nutr 2007;86(6):1595–1602. Dec. Links.PubMed
33.
Schauer P, Chand B, Brethauer S. New applications for endoscopy: the emerging field of endoluminal and transgastric bariatric surgery. Surg Endosc 2007;21(3):347–356. Epub 2006 Dec 16, Mar.PubMedCrossRef
34.
Salmon PA, McArdle MO. Horizontal and vertical gastroplasties: extended follow-up and late results. Obes Surg 1992;2(1):51–59. Feb.PubMedCrossRef
35.
Koopmans HS, Sclafani A. Control of body weight by lower gut signals. Int J Obes 1981;5:491–495.PubMed
36.
Strader AD, Vahl TP, Jandacek RJ, Woods SC, D’Alessio DA, Seeley RJ. Weight loss through ileal transposition is accompanied by increased ileal hormone secretion and synthesis in rats. Am J Physiol Endocrinol Metab 2005;288(2):E447–E453. Feb.PubMedCrossRef
37.
Blanpain C, Horsley V, Fuchs E. Epithelial stem cells: turning over new leaves. Cell 2007;128(3):445–458. Feb 9.PubMedCrossRef
38.
Cigaina V, Hirschberg AL. Gastric pacing for morbid obesity: plasma levels of gastrointestinal peptides and leptin. Obesity 2003;11(12):1456–1462. December 1.CrossRef
39.
Wang GJ, Yang J, Volkow ND, Telang F, Ma Y, Zhu W, Wong CT, Tomasi D, Thanos PK, Fowler JS. Gastric stimulation in obese subjects activates the hippocampus and other regions involved in brain reward circuitry. Proc Natl Acad Sci U S A 2006;103(42):15641–15645. Oct 17.PubMedCrossRef
40.
Miller K, Hoeller E, Aigner F. The implantable gastric stimulator for obesity: an update of the European Experience in the LOSS (Laparoscopic Obesity Stimulation Survey) Study. Treat Endocrinol 2006;5(1):53–58.PubMedCrossRef
41.
Qin C, Sun Y, Chen JDZ, Foreman R. Effects of gastric electrical stimulation on neuronal activity in nucleus tractus salitarii (NTS). Gastroenterology 2004;126:A10.
42.
Roslin M, Kurian M. The use of electrical stimulation of the vagus nerve to treat morbid obesity. Epilepsy Behav 2001;2(3 Pt 2):S11–16.CrossRef
43.
Apovian CM, Baker C, Ludwig DS, Hoppin AG, Hsu G, Lenders C, Pratt JSA, Forse RA, O’Brien A, Tarnoff M. Best practice guidelines in pediatric/adolescent weight loss surgery. Obes Res 2005;13:274–279.PubMedCrossRef
44.
Fontaine KR, Redden DT, Wang C, Westfall AO, Allison DB. Years of life lost due to obesity. JAMA 2003;289:187–193.PubMedCrossRef
45.
Tsai WS, Inge TH, Burd RS. Bariatric surgery in adolescents: recent national trends in use and in-hospital outcome. Arch Pediatr Adolesc Med 2007;161:217–221.PubMedCrossRef
46.
Novak CM, Levine JA. Central neural and endocrine mechanisms of non-exercise activity thermogenesis and their potential impact on obesity. J Neuroendocrinol 2007;19(12):923–940. Dec.PubMedCrossRef
47.
Kring SI, Holst C, Zimmermann E, Jess T, Berentzen T, Toubro S, Hansen T, Astrup A, Pedersen O, Sørensen TI. FTO gene associated fatness in relation to body fat distribution and metabolic traits throughout a broad range of fatness. PLoS ONE 2008;3(8):e2958. Aug 13.PubMedCrossRef
48.
Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006;444(7122):1027–1031. Dec 21.PubMedCrossRef
49.
Knutson KL, Van Cauter E. Associations between sleep loss and increased risk of obesity and diabetes. Ann N Y Acad Sci 2008;1129:287–304.PubMedCrossRef
50.
Fetissov SO, Hamze Sinno M, Coëffier M, Bole-Feysot C, Ducrotté P, Hökfelt T, Déchelotte P. Autoantibodies against appetite-regulating peptide hormones and neuropeptides: putative modulation by gut microflora. Nutrition 2008;24(4):348–359. Epub 2008 Feb 8, Apr.PubMedCrossRef
Metadaten
Titel
Bariatric Surgery: A History of Empiricism, a Future in Science
verfasst von
John C. Alverdy
Vivek Prachand
Brody Flanagan
William A. Thistlethwaite
Mark Siegler
Marc Garfinkel
Peter Angelos
Shailesh Agarwal
Heena Santry
Publikationsdatum
01.03.2009
Verlag
Springer-Verlag
Erschienen in
Journal of Gastrointestinal Surgery / Ausgabe 3/2009
Print ISSN: 1091-255X
Elektronische ISSN: 1873-4626
DOI
https://doi.org/10.1007/s11605-008-0742-1

Weitere Artikel der Ausgabe 3/2009

Journal of Gastrointestinal Surgery 3/2009 Zur Ausgabe

original article

Dendritic Cell-Associated Immune Inflammation of Cardiac Mucosa: A Possible Factor in the Formation of Barrett’s Esophagus

2008 ssat other

Diverting Ostomy with Pouch Procedure: “Causes More Morbidity Than It Prevents!”

2008 ssat quickshot presentation

Intestinal Afferent Nerve Sensitivity is Increased During the Initial Development of Postoperative Ileus in Mice

original article

Use of Positron Emission Tomography in Surgery Follow-Up of Esophageal Cancer

gi image

Total Gastrointestinal Tract Necrosis After Ingesting a Considerable Amount of Hydrochloric Acid

original article

Clinicopathologic Characteristics of Hepatocellular Carcinoma with Bile Duct Invasion

Neu im Fachgebiet Chirurgie

23.04.2024 | Ablationstherapie | Nachrichten

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 | Appendizitis | Nachrichten

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 | Operationsvorbereitung | Nachrichten

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

19.04.2024 | EAU 2024 | Kongressbericht | Nachrichten

Ureterstriktur: Innovative OP-Technik bewährt sich
weitere anzeigen

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.